bpc-157 cancer risk is being marketed as a “healing peptide” for tendon injuries, joint pain, gut repair, inflammation, and recovery. The problem is that “healing” biology is not always simple in people with The FDA is reviewing seven

Breckas team have put thousands of patients on BPC-157 without a reported adverse event (source)

Most common causes of the discolouration include: Medications amino-salicyclic acid derivatives mesalazine/paraaminosalycylic acid/sulfasalazine doxorubicin , hydroxocobalamin , ibuprofen, phenothiazines, phenolphthalein, propofol , rifampicin/rifampin Dietary ingestants beeturia , rhubarb, blackberries, food dyes Metabolic abnormalities porphyria , urate crystals Hydroxocobalamin Early features of cyanide poisoning include nausea, vomiting, headache, dyspnoea, tachypnoea, hypertension, tachycardia, collapse and seizures

How Long Until I See Results With BPC 157

Starting at lower dose ranges and titrating based on tolerability and response represents a conservative approach consistent with general peptide therapy principles

I love how quickly this works